Kapak Resmi

C1q and HBHA-specific IL-13 levels as surrogate plasma biomarkers for monitoring tuberculosis treatment efficacy: a cross-sectional cohort study in Paraguay

Correspondence: Graciela Russomando, grusso@rieder.net.py; Jonathan Hoffmann, jonathan.hoffmann@fondation-merieux.org

Kaydedildi:

Detaylı Bibliyografya
Yazar:	Russomando Alvarez, Graciela Mabel (author)
Diğer Yazarlar:	Sanabria Martínez, Diana Leticia (author), Díaz Acosta, Chyntia Carolina (author), Arenas, Rossana (author), Rojas Vera, Leticia Elizabeth (author), Franco, Laura Ximena (author), Arenas Chaparro, María Rossana (author), Delogu, Giovanni (author), Bousso Ndiaye, Mame Diarra (author), Bayaa, Rim (author), Rakotosamimanana, Niaina (author), Goletti, Delia (author), Hoffmann, Jonathan (author)
Materyal Türü:	article
Dil:	İngilizce
Baskı/Yayın Bilgisi:	2024
Konular:	7. Salud 7.3. Prevención, vigilancia y control de enfermedades transmisibles y no transmisibles Host biomarkers Immunodiagnostic Plasma protein signature Pulmonary tuberculosis Treatment immunomonitoring 3. Ciencias Médicas y de la Salud 3.3. Ciencias de la Salud (salud pública, medicina social, higiene, enfermería, epidemiología)
Online Erişim:	https://doi.org/10.3389/fimmu.2024.1308015 http://hdl.handle.net/20.500.14066/4587
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

İlk yorumlayan siz olun!